Eli Lilly to apply for approval of anti-obesity drug retatrutide in 2027
The Eli Lilly logo appears at the company's office in San Diego, California, on November 21, 2025. Mike Blake |…
health care industry
What the FDA's Taylor Farms Lettuce False Positive Means
Packages of Taylor Farms salad greens are displayed at a Safeway store on July 16, 2026 in Kings Beach, California.…
Taco Bell removes lettuce linked to cyclosporiasis outbreak from restaurants
Customers enter a Taco Bell restaurant on July 14, 2026 in La Cañada Flintridge, California. Mario Tama | fake images…
Trump criticizes Canada over wildfire smoke, threatens to raise tariffs
Smoke from massive wildfires in Canada envelops the New York City skyline, reducing visibility and casting an orange haze over…
UnitedHealth Group (UNH) earnings in the second quarter of 2026
UnitedHealth Group on Thursday posted second-quarter earnings that beat estimates and raised its full-year profit outlook as the company better…
The biotechnology recovery is not a farce. These 3 stocks could lead the next bullish leg
The stock market's attention has been focused almost exclusively on artificial intelligence, semiconductors and a handful of large-cap technology companies.…
Cramer Says This Stock Is Significantly Undervalued And Sees 35% Upside
Every weekday, CNBC's Investment Club with Jim Cramer hosts a livestream “morning meeting” at 10:20 a.m. ET. Here's a recap…
Employers Are Not Expanding Coverage of GLP-1 Anti-Obesity Drugs: Survey
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
AstraZeneca trial failure raises bigger questions about its portfolio
AstraZenecaWainua's failed final trial was never expected to have a major financial impact on the company. Most analysts estimate that…
Abivax receives $920 million in cash to prepare for US launch: CEO
AbivaxThe latest round of funding allows the biotech to move toward launching its intestinal disease drug in the United States…